Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha.
about
Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta roleThe dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma.Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosisRegulation of porcine plasmacytoid dendritic cells by cytokinesImmune suppression in head and neck cancers: a reviewImmunotherapy for head and neck cancer: advances and deficiencies.The polarization of immune cells in the tumour environment by TGFbeta.Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.Human plasmacytoid dendritic cells: from molecules to intercellular communication networkPlasmacytoid Dendritic Cells: Neglected Regulators of the Immune Response to Staphylococcus aureus.TGF-β1 inhibits the production of IFN in response to CpG DNA via ubiquitination of TNF receptor-associated factor (TRAF) 6.HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells.The Innate Immune Response Against Staphylococcus aureus.Plasmacytoid dendritic cells and their therapeutic activity in cancerAccumulation of plasmacytoid DC: Roles in disease pathogenesis and targets for immunotherapy.Disease-Associated Plasmacytoid Dendritic Cells.[Immunotherapy of head and neck cancer. Current developments].S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells.Cancer-associated fibroblasts regulate the biological behavior of cancer cells and stroma in gastric cancer.Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells.Local Immunotherapy of Cancer: Innovative Approaches to Harnessing Tumor-Specific Immune Responses.Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".Prostaglandin E2 Antagonizes TGF-β Actions During the Differentiation of Monocytes Into Dendritic Cells.Arginase I, Polyamine, and Prostaglandin E2Pathways Suppress the Inflammatory Response and Contribute to Diffuse Cutaneous LeishmaniasisEpithelial control of the human pDC response to extracellular bacteriaImmune suppression and evasion in patients with head and neck cancer
P2860
Q26769734-D930651A-A2D3-4E7F-B1D1-59C2002477CFQ30317628-E849A016-F9B1-407C-90E2-5AF1DB13F1C6Q33565624-D4B5BBB6-38A1-4228-A29D-BE518BC3AE41Q33678336-F3FD92B7-A2A4-4400-9565-0EA44A897B4CQ34664032-28584320-8F3B-4DBD-A5E9-47386EFB63E9Q34700675-A585E523-8AFD-4424-BD4C-55C2899E774EQ35072040-460803F1-5328-4E23-AAE9-78C428905667Q37454364-E8F5A4F0-ED2B-4E57-9E66-2A58CAE8D397Q37829504-2D185F19-D3BB-45A7-946E-BD09689862BAQ38166716-B3D91A3E-1037-4DAC-BD10-694060B72CC7Q38218117-47ECD7B5-11DA-425F-8389-879502C33CC1Q38297340-3FFBFB5A-FF54-426A-8A18-781A64CAE8F3Q38930365-8D99DAF5-A8C5-415F-B66D-69946157A659Q40871546-A6460DEA-ADC5-407B-90BA-70C6550FF08EQ42321646-86734151-6115-46CC-BA0F-DB7E9FD7462FQ43063046-E6F6A67F-4CC9-40C2-A67F-B52CA953515AQ43930865-6172FAFF-9EE0-4EB6-8630-7BA2F7687390Q45770749-2D9A4CC2-61A7-4AE0-87B5-C3470A61ACB8Q48259591-BB0EC9C3-0F44-4932-8FD4-C0BD5523E9E4Q49335261-47906D3A-168A-4A5D-A520-52F00B102A32Q51832626-0B4575CB-2CD0-4F01-BA75-1E7C6CA82F2EQ52353493-842EDA9F-79B0-4A54-A29F-CF0E82378B0FQ54378300-B204CCC0-296D-4152-B5F1-BBF82D60D495Q55456463-2C87B667-96AC-4CAD-91CD-FB1E3829625CQ56798088-5AFCEE9F-A2AC-4308-8139-23EB599C53F6Q57612612-9A4B538C-5E7F-4968-970B-D0655F681316Q58289735-316DE020-18CC-4BA1-99E4-2D0811C5A851
P2860
Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Tumour-derived prostaglandin E ...... cell-derived interferon-alpha.
@en
Tumour-derived prostaglandin E ...... cell-derived interferon-alpha.
@nl
type
label
Tumour-derived prostaglandin E ...... cell-derived interferon-alpha.
@en
Tumour-derived prostaglandin E ...... cell-derived interferon-alpha.
@nl
prefLabel
Tumour-derived prostaglandin E ...... cell-derived interferon-alpha.
@en
Tumour-derived prostaglandin E ...... cell-derived interferon-alpha.
@nl
P2093
P2860
P1433
P1476
Tumour-derived prostaglandin E ...... cell-derived interferon-alpha.
@en
P2093
Barbara Wollenberg
Evelyn Hartmann
Isabelle Bekeredjian-Ding
Marijo Parcina
Meike Schäfer
Philip Schneider
Ralph Pries
Stefan Endres
Thomas Giese
P2860
P304
P356
10.1111/J.1365-2567.2009.03134.X
P577
2009-11-01T00:00:00Z